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Gap junction (GJ) channels are formed by two hemichannels (connexons), each contributed by the cells taking part in this
direct cell–cell communication conduit. Hemichannels that do not interact with their counterparts on neighboring cells
feature as a release pathway for small paracrine messengers such as nucleotides, glutamate, and prostaglandins. Con-
nexins are phosphorylated by various kinases, and we compared the effect of various kinase-activating stimuli on GJ
channels and hemichannels. Using peptides identical to a short connexin (Cx) amino acid sequence to specifically block
hemichannels, we found that protein kinase C, Src, and lysophosphatidic acid (LPA) inhibited GJs and hemichannel-
mediated ATP release in Cx43-expressing C6 glioma cells (C6-Cx43). Lipopolysaccharide (LPS) and basic fibroblast growth
factor (bFGF) inhibited GJs, but they stimulated ATP release via hemichannels in C6-Cx43. LPS and bFGF inhibited
hemichannel-mediated ATP release in HeLa-Cx43 cells, but they stimulated it in HeLa-Cx43 with a truncated carboxy-
terminal (CT) domain or in HeLa-Cx26, which has a very short CT. Hemichannel potentiation by LPS was inhibited by
blockers of the arachidonic acid metabolism, and arachidonic acid had a potentiating effect like LPS and bFGF. We conclude
that GJ channels and hemichannels display similar or oppositely directed responses to modulatory influences, depending on
the balance between kinase activity and the activity of the arachidonic acid pathway. Distinctive hemichannel responses to
pathological stimulation with LPS or bFGFmay serve to optimize the cell response, directed at strictly controlling cellular ATP
release, switching from direct GJ communication to indirect paracrine signaling, or maximizing cell-protective strategies.
INTRODUCTION
Gap junctions (GJs) are specialized structures composed of a
collection of channels that directly connect adjacent cells to
allow the passage of small molecules such as amino acids, ions,
and second messengers. Vertebrate GJ channels are composed
of proteins encoded by the connexin gene family (Sohl and
Willecke, 2004). Connexins span the membrane four times, are
endowed with a single cytoplasmic loop and two extracellular
loops, and have their amino and carboxy terminals (CTs) inside
the cell. Most of the connexins are phosphorylated in vivo,
primarily on serine residues and to a lesser extent on threonine
and tyrosine residues located in the CT domain. Cx43 is a
ubiquitously expressed connexin that has been well character-
ized in terms of phosphorylation sites and effects. A basal
degree of phosphorylation on five serine residues seems to be
required for the assembly and functioning of GJs composed of
Cx43 (Musil and Goodenough, 1991; Laird et al., 1995; Cooper
et al., 2000). Numerous studies have demonstrated the influ-
ence of growth factors, oncogene protein kinases, hormones,
and inflammatory mediators on GJ communication via phos-
phorylations on the CT domain of the protein (amino acid
236–382) (Maldonado et al., 1988; Crow et al., 1990; Filson et al.,
1990; Swenson et al., 1990; Kurata and Lau, 1994; Matesic et al.,
1994). Several serine kinases have been identified, including
protein kinase C (PKC) (Ser 368 and Ser 372), mitogen-acti-
vated protein kinases (MAPKs) (Ser 255, Ser 279, and Ser 282),
cdc2/cyclinB (Ser 255), and casein kinase I (Ser 325, Ser 328,
and Ser 330) (Lampe and Lau, 2004).
GJ channels are composed of two hemichannels, each
contributed by the cells that share this junctional communi-
cation channel. Hemichannels are hexameric high-conduc-
tance plasma membrane channels that are normally closed
and can act as a conduit to release paracrine signaling mol-
ecules such as ATP, NAD, glutamate, and prostaglandins
when opened (Bruzzone et al., 2001b; Bennett et al., 2003;
Ebihara, 2003; Goodenough and Paul, 2003; Ye et al., 2003;
Cherian et al., 2005). Hemichannels are closed at physiolog-
ical millimolar extracellular calcium concentrations, but they
open in response to lowering extracellular calcium (alone or
in combination with a lowering of other extracellular diva-
lent cations) (Li et al., 1996; Pfahnl and Dahl, 1999; Quist et
al., 2000; Kamermans et al., 2001; Muller et al., 2002; Stout and
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Charles, 2003; Ye et al., 2003; Thimm et al., 2005; Srinivas et
al., 2006), strong membrane depolarization (Trexler et al.,
1996), mechanical stimulation (Bao et al., 2004a; Gomes et al.,
2005), extracellular UTP (Cotrina et al., 1998), metabolic in-
hibition (John et al., 1999; Kondo et al., 2000; Contreras et al.,
2002; Vergara et al., 2003), shigella infection (Tran Van Nhieu
et al., 2003), and most recently also in response to an increase
of cytoplasmic calcium (De Vuyst et al., 2006). Hemichannels
have been reported to be inhibited by kinases such as PKC
or Src (Li et al., 1996; Bruzzone et al., 2001a; Bao et al., 2004b).
The purpose of the present study was to determine whether
GJ channels and hemichannels are similarly or differentially
influenced by various kinases or kinase-activating stimuli.
Both channels and hemichannels are composed of the same
connexin building blocks and would, at first glance, be
expected to respond similarly to phosphorylations. Both
channel types are, however, differentially regulated to start
with, GJs being open under resting conditions and
hemichannels being closed to prevent cell leakage.
Our work demonstrates that although channels and
hemichannels are influenced in the same direction by certain
stimuli, e.g., inhibition by PKC, Src, or LPA, both channels
are differentially influenced by lipopolysaccharide (LPS) and
basic fibroblast growth factor (bFGF), depending on the cell
type and the presence or absence of the CT domain. In
C6-Cx43 cells, LPS and bFGF potentiated ATP release via
hemichannels, whereas in HeLa-Cx43 cells both substances
inhibited these responses. Removal of the CT domain in
HeLa-Cx43 cells reduced the ATP release, but LPS or bFGF
treatment now potentiated the hemichannel-mediated ATP
response. Likewise, HeLa cells expressing Cx26, which has a
short CT domain, displayed hemichannel potentiation by
LPS and bFGF. Antagonists of the arachidonic acid metab-
olism inhibited LPS enhancement of ATP release, and ara-
chidonic acid itself mimicked the potentiation effect of LPS
or bFGF. The cell specificity of hemichannel responses thus
seemed to depend on the balance between phosphorylations
(inhibition) and activation of the arachidonic acid signaling
cascade (stimulation). LPS and bFGF came up as the most
versatile modulators of connexin channels, because they
Figure 1. ATP release triggered in C6-Cx43 by DF exposure is
mediated by hemichannels. (A) Exposure to DF conditions triggered
significant ATP release that was blocked by carbenoxolone and the
connexin mimetic peptides gap 26 and 27. (B) Botulinum toxin B
and bafilomycin A1 had no inhibitory effects; botulinum toxin B
even stimulated DF-triggered ATP release. Numbers on the bars
indicate n. Star symbols indicate significant differences compared with
baseline, whereas the number signs indicate significant differences
compared with the corresponding control bar (single symbol, p 0.05;
double symbol, p 0.01; and triple symbol, p 0.001). Gap 26 and 27
also significantly depressed baseline ATP release (p 0.001 and 0.02
respectively; t test; not indicated on the graph).
Figure 2. Effect of CT-truncation on GJ coupling and ATP release
in HeLa-Cx43. (A) Example pictures of FRAP experiments used to
investigate dye coupling. The white arrow points to the photo-
bleached cell. (B) Average FRAP recovery traces of the experiments
summarized in C. (C) Summary FRAP recovery data determined
from data points over the last 25 s. CT truncation had no effect on GJ
coupling (n is number of FRAP experiments on 2 different cultures).
(D) CT-truncation largely depressed baseline and triggered ATP
release. Stars indicate significant differences compared with base-
line; number signs indicate significant differences compared with
HeLa-Cx43. Baseline in HeLa-Cx43 C was significantly below
baseline in HeLa-Cx43 (p  0.0001; t test).
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invariably inhibited GJs, but they inhibited or potentiated
hemichannels depending on the dominance of kinase or
arachidonic acid effects. The immunostimulant LPS and the
growth factor bFGF thus exert powerful control over the
release of ATP via hemichannels, a purine messenger that
has both immune-modulatory and mitogenic actions (Fields
and Burnstock, 2006). In addition, hemichannels play, like
GJs, a role in cell death signaling, either as an antiapoptotic
gate or a pathogenic pore (Plotkin et al., 2002; Hur et al., 2003;
Kalvelyte et al., 2003; Krysko et al., 2005; Evans et al., 2006).
Distinctive hemichannel responses may thus aim at optimiz-
ing cell–cell communication (stimulation of hemichannels
compensating for the decreased GJ communication) or cell
protection (inhibition of hemichannels), depending on the
conditions and the cell type.
MATERIALS AND METHODS
Cells and Reagents
We used the following cell lines: C6 rat glioma cells stably transfected with
Cx43 (C6-Cx43) (Zhu et al., 1991), human epithelial HeLa cells stably trans-
fected with Cx43 (HeLa-Cx43) or the truncated form of Cx43 (HeLa-Cx43C)
(Omori and Yamasaki, 1999), HeLa cells stably transfected with Cx26 (Mesnil
et al., 1996), and human embryonic kidney (HEK)-293 stably transfected with
P2X7 (HEK-P2X7) (Humphreys et al., 1998). C6-Cx43 was maintained in
DMEM/Ham’s F-12 (1:1), and the HeLa and HEK lines were maintained in
DMEM (HEK cells received in addition Geniticin at 300 g/ml). All media
were supplemented with 10% fetal bovine serum and 2 mM glutamine. All
cell culture reagents were obtained from Invitrogen (Merelbeke, Belgium).
Six-carboxyfluorescein, (6-CF), calcein-acetoxymethyl ester (AM) and 5-car-
boxyfluorescein diacetate (5-CFDA) were from Invitrogen. Phorbol 12-myristate
13-acetate (PMA), l--lysophosphatidic acid (LPA), LPS (Escherichia coli O111:
B4), bafilomycin A1, botulinum toxin B, PD098.059, U0126, chelerythrine,
genistein, arachidonic acid, indomethacin, and carbenoxolone were obtained
Figure 3. Effects of PKC and Src in C6-Cx43. (A) Average FRAP recovery traces (n  31) in control and after PKC activation with PMA (n 
19). (B) FRAP summary data, showing inhibition of dye coupling by PMA and reversal by chelerythrin or PMA washout (30 min) (n is
number of FRAP experiments on 3 different cultures for control and 2 different cultures for all other conditions). (C) Triggered ATP release
was inhibited by PMA, an effect that was reversed by chelerythrin. (D) Example pictures illustrating SLDT in control and c-SrcK-transfected
cells. The right border of the scrape is visible as the row of strongly 6-CF–stained cells, and dye spread proceeded from there to the right (bar,
100 m). A fluorescence intensity profile was derived from each image, and a spatial constant of exponential decay was determined. (E)
Summary data of SLDT experiments. Dye coupling was not significantly affected by mock or c-SrcK transfection, but it was significantly
inhibited in c-SrcK (n is number of SLDT images obtained in 4 different cultures for control and 2 different cultures for all other conditions).
(F) Triggered ATP release was not affected in mock or c-SrcK, but it was significantly depressed in c-SrcK. Stars indicate significant
differences compared with control in B and E and compared with baseline in C and F. Number signs in C and F indicate significant differences
compared with control. PMA significantly depressed baseline ATP release in C (p  0.001; t test).
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from Sigma (Bornem, Belgium). 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyra-
zolo[3,4-d]pyrimidine (PP2) was from BIOMOL Research Laboratories (Ply-
mouth Meeting, MA), bFGF was from Roche Diagnostics (Vilvoorde, Belgium),
AACOCF3 and baicalein were from Tocris Cookson (Avonsmouth, United King-
dom), and ampicillin was from Invitrogen. The connexin mimetic peptides gap
26 (VCYDKSFPISHVR) and gap 27 (SRPTEKTIFII) were synthesized by Sigma-
Genosys (Cambridge, United Kingdom).
Plasmid DNA Purification and Transfection
pcDNA constructs containing dominant-negative and dominant-positive mu-
tants of Src kinase were kindly provided by Dr. W. H. Moolenaar (Division of
Cellular Biochemistry and Center for Biomedical Genetics, The Netherlands
Cancer Institute, Amsterdam, The Netherlands) (Giepmans et al., 2001). Con-
structs (pcDNA3.1, pcDNA-SrcK, pcDNA-SrcK, and pDSRed, used as a
marker for transfection efficiency) were transformed to DH5 heat-shock–
competent bacteria and grown overnight on Luria broth (LB) agar plates. A
single colony was picked up and grown in liquid LB media supplemented
with ampicillin overnight. The next day, bacteria were harvested by centrif-
ugation, and DNA was isolated using Midi kits (QIAGEN, Benelux, The
Netherlands). Cells were seeded at a density of 25,000 cells/cm2 and trans-
fected 6 h after seeding with 0.45 ng of pcDNA plasmid and 0.05 ng of
pDSRed plasmid/cm2 by using Transfectin lipid reagent (Bio-Rad, Nazareth,
Belgium), except for ATP measurements where pDSRed was excluded.
GJ Communication
GJ dye coupling was determined with fluorescence recovery after photo-
bleaching (FRAP) or scrape loading and dye transfer (SLDT). For FRAP,
confluent monolayer cultures grown on glass-bottomed microwell (MarTek,
Ashland, MA) were loaded with 10 M 5-CFDA or 5 M calcein (used for
HeLa-Cx26) in Hank’s balanced salt solution (HBSS)-HEPES for 45 min at
room temperature. Fluorescence within a single cell was photobleached by
spot exposure to the 488-nm line of an Argon laser and imaging (again at
488-nm excitation) was done with a custom-made video-rate confocal laser
scanning microscope (Leybaert et al., 2005) with a 40 oil immersion objective
(CFI Plan Fluor; Nikon, Tokyo, Japan). For SLDT, confluent monolayer cul-
tures were washed three times with nominally calcium-free (CF)-HBSS-
HEPES. Cells were incubated during 1 min in CF-HBSS-HEPES containing 0.4
mm 6-CF; a linear scratch (1 per culture) was made across the culture by using
a syringe needle, and the cells were left for another minute in the same
solution. Cultures were then washed four times with HBSS-HEPES, left for 15
min at room temperature, and images were taken with a Nikon TE300
inverted microscope in epifluorescence mode (tetramethylrhodamine B iso-
thiocyanate excitation/emission) with a 10 objective and a Nikon DS-5M
camera (Analis, Namur, Belgium). A fluorescence diffusion profile was de-
rived from the images, fitted to a mono-exponential decaying function, and a
spatial constant of intercellular dye spread was determined.
Cellular ATP Release
ATP release was measured with an ATP bioluminescent luciferin/luciferase
assay kit (Sigma) in combination with a luminometer plate reader (Victor3
1420 multi label counter; Perkin-Elmer, Zaventem, Belgium) on subconfluent
cultures grown on 24-well plates (BD Bioscience, Erembodegem, Belgium).
Cells were seeded at a density of 25,000 cells/cm2 and used the next day for
experiments. ATP release was triggered with divalent-free (DF) HBSS-HEPES
(Ca2 and Mg2 replaced with 4 mM EGTA), and ATP was accumulated over
a 2.5-min stimulation period. Baseline measurements were done according to
the same procedure but with standard HBSS-HEPES instead. ATP assay mix
(75 l), prepared in HBSS-HEPES (at 5-fold dilution), was added to 150 l of
solution bathing the cells, and the photon flux was counted over 10 s at the
end of the 2.5-min stimulation period. Average ATP release in C6-Cx43 cells
was 23.5  2.4 pmol (n  176) in baseline and 46.2  3.4 pmol (n  183) with
DF stimulation. All pharmacological agents were preincubated for the times
indicated, in HBSS-HEPES at room temperature or in culture medium at 37°C
for incubations lasting 30 min or longer, and were not present during the
2.5-min stimulation.
Western Blotting
Cell protein lysates were extracted by treatment of confluent cultures with
radioimmunoprecipitation assay buffer (25 mM Tris, 50 mM NaCl, 0.5%
NP-40, 0.5% deoxycholate, 0.1% SDS, 0.055 g/ml -glycerophosphate, 1 mM
dithiothreitol, 20 l/ml phosphatase inhibitor cocktail, and 20 l/ml mini
EDTA-free protease inhibitor cocktail) and sonicated by three 10-s pulses.
Separation of Triton X-100–soluble and –insoluble material was done essen-
tially according to the method of Cooper and Lampe (2002). After appropriate
treatment, cells from 75-cm2 culture flasks were washed two times with
phosphate-buffered saline (PBS), pH 7.2. Cells were harvested in ice-cold 1%
Triton X-100 in PBS supplemented with 50 mM NaF, 1 mM Na3VO4, 1%
protease inhibitor cocktail, 1% phosphatase inhibitor cocktail 1 and 2 (Sigma),
and 1X mini-EDTA-free protease inhibitor cocktail (Roche Diagnostics, Pen-
zberg, Germany). These samples were separated into Triton-soluble and
-insoluble fractions by centrifugation at 16,000  g for 10 min. Triton-insol-
uble fractions (pellets) were resuspended in 1X Laemmli sample buffer and
sonicated by five 10-s pulses. Protein concentration was determined with a
Bio-Rad DC protein assay kit (Bio-Rad), and absorbance was measured on a
plate reader with a 590-nm long-pass filter. Proteins were separated by
electrophoresis on a 10% SDS-polyacrylamide gel and transferred to a nitro-
cellulose membrane (GE Healthcare, Little Chalfont, Buckinghamshire,
United Kingdom). Blots were probed with a rabbit polyclonal anti-rat Cx43
antibody (1/10,000; Sigma), a rabbit polyclonal anti-rat -tubulin antibody
(1/5000, loading control; Abcam, Cambridge, United Kingdom), a mouse
monoclonal anti-rat Cx43 antibody (1/500, epitope located at the intracellular
loop; Upstate Cell Signaling, Huissen, The Netherlands), a rabbit polyclonal
anti-rat Cx26 (1/2000; Zymed, Invitrogen), or a polyclonal rabbit anti-rat P2X7
antibody (1/1000; Alomone Labs, Jerusalem, Israel) followed by alkaline
phosphatase-conjugated goat anti-rabbit IgG or goat anti-mouse IgG (1/8000-
1/4000; Sigma), and detection was done with nitro blue tetrazolium/5-bro-
mo-4-chloro-3-indolyl phosphate reagent (Zymed, Invitrogen). Specificity of
the P2X7 receptor antibody was confirmed by competition experiments with
an antigenic peptide corresponding to amino acids 576–595 of the rat P2X7
receptor. ImageJ (http://rsb.info.nih.gov/ij/) was used to quantify Western
blot signals. A rectangular measurement window was drawn around the
nonphosphorylated (P0) and phosphorylated bands (P1  2), and their respec-
tive intensities were determined. The same windows were used to measure the
background signal in nitrocellulose membrane zones where no protein was
present; this background was subtracted form the P0 and P1  2 signals. The
degree of phosphorylation was then calculated as the ratio between P1  2 and P0,
which was set to 100% for the control condition.
Data Analysis and Statistics
The data are expressed as mean  SEM with n (indicated on the bar graphs)
denoting the number of experiments. Comparison of two groups was done
with a one-tailed unpaired t test with a p value below 0.05 indicating signif-
icance. Comparison of more than two groups was done with one-way analysis
of variance (ANOVA) and a Bonferroni posttest. Statistical significance is
indicated in the graphs with a single symbol (* or #) for p 0.05, two symbols
for p  0.01, and three symbols for p  0.001. Some substances or treatments
also influenced the baseline signal, but these effects most often did not reach
Figure 4. Effects of LPA treatment in C6-Cx43. (A) GJ coupling
(FRAP) was significantly inhibited by LPA, and this was reversed
by PP2 and U0126 but not by chelerythrin or PD098.059 (n is
number of FRAP experiments on 5 different cultures for control and
2 different cultures for all other conditions). (B) Triggered ATP
release was significantly inhibited by LPA, an effect that was re-
versed by PP2 and U0126, but not by chelerythrin and PD098.059.
Stars indicate significant differences compared with control in A and
compared with baseline in B. The number signs in B indicate sig-
nificant differences compared with control.
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significancy with ANOVA. Selected comparisons for baseline effects were
redone with a t test, and significant differences, if relevant, are given in the
figure legend.
RESULTS
ATP Release Triggered in Cx43-transfected Cells by
Divalent-free Extracellular Conditions Is Related to
Hemichannel Opening
Incubating C6 glioma cells stably transfected with Cx43 (C6-
Cx43) (Zhu et al., 1991) in divalent cation-free (DF) solutions
triggered ATP release that was significantly above baseline
(Figure 1A), as reported previously (Arcuino et al., 2002; Stout
and Charles, 2003; Ye et al., 2003). DF-triggered ATP release in
C6-Cx43 was significantly suppressed by the GJ blocker car-
benoxolone (25M; 15 min), the connexin mimetic peptide gap
26 (amino acids 64–76 on the first extracellular loop of Cx43),
and gap 27 (amino acids 201–211 on the second extracellular
loop) (Figure 1A). These peptides specifically block Cx43
hemichannels and not GJ channels when applied 30 min at 0.25
mg/ml (Braet et al., 2003a,b; Leybaert et al., 2003; Evans et al.,
2006). Gap 26 and 27 also significantly reduced baseline ATP
release (Figure 1A), indicating the presence of open hemichan-
nels without DF stimulation. Botulinum toxin B, a blocker of
vesicular release that cleaves synaptobrevin (1.5 nM; 24 h)
(Schiavo et al., 1992) or bafilomycin A1 (100 M; 1 h), a v-
ATPase inhibitor known to inhibit ATP storage (Coco et al.,
Figure 5. Effects of LPS treatment in C6-Cx43. (A) GJ coupling
(FRAP) was inhibited by LPS, and this was reversed by PP2 and
U0126, not by chelerythrin or PD098.059 (n is number of FRAP
experiments on 5 different cultures for control and 2 different cul-
tures for all other conditions). (B) Triggered ATP release was sig-
nificantly enhanced by LPS, an effect that was reversed by PP2 and
U0126, but not by chelerythrin. (C) LPS enhancement of ATP release
was strongly inhibited by gap 27, to an extent comparable to that in
Figure 1A. (D) Bafilomycin A1 had no effect. Stars indicate signifi-
cant differences compared with control in A and compared with
baseline in B–D; number signs indicate significant differences com-
pared with control. LPS also significantly stimulated baseline ATP
release (p  0.001 in B, 0.05 in C, and 0.001 in D; t test).
Figure 6. Effect of CT-truncation on LPA and LPS modulation of
ATP release in HeLa-Cx43. (A) Experiments on HeLa-Cx43 illustrat-
ing inhibition of triggered ATP release by LPA and LPS. Gap 27
blocked the triggered ATP release, whereas botulinum toxin B had
no effect (gap 27 also inhibited baseline ATP release, as noted in
Figure 1A, p  0.0001). (B) Experiments on CT-truncated HeLa-
Cx43 illustrating absence of triggered ATP release in these cells, no
effect of LPA, but significant stimulation of triggered ATP release by
LPS. Gap 27 blocked the LPS-enhanced ATP response, but botuli-
num toxin B had no effect, analogous to the experiments on C6-Cx43
illustrated in Figure 5, C and D. Stars indicate significant differences
compared with baseline, whereas the number signs indicate signif-
icant differences compared with control.
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2003), did not diminish triggered ATP release (Figure 1B).
Activation of the P2X7 receptors with subsequent opening of a
large ATP-permeable pore is another pathway for ATP release
(Chessell et al., 1997; Duan et al., 2003), but Western blots did
not indicate P2X7 receptor expression in C6-Cx43 (Figure 10A),
and exposure to the P2X7 receptor pore inhibitors Ox-ATP (100
M; 2 h) and KN62 (1 M; 1 h) did not significantly affect
DF-triggered ATP release in C6-Cx43 cells (data not shown).
DF conditions also triggered ATP release in HeLa cells stably
transfected with Cx43 (HeLa-Cx43) (Omori and Yamasaki, 1999),
and this response was, like in C6-Cx43, blocked by gap 27 and not
influenced by botulinum toxin B (Figure 6A); HeLa-Cx43 cells,
like C6-Cx43, did not express P2X7 receptors (Figure 10A).
CT Truncation of Cx43 Does Not Affect
GJ Communication but Abolishes ATP Responses in
HeLa-Cx43
The CT of Cx43 is known to contain multiple consensus
phosphorylation sites for PKC, Src, and MAPK (Warn-
Cramer and Lau, 2004). To determine the gross effect of
phosphorylations at these sites, we performed experiments
on HeLa-Cx43 with the CT-truncated at position 239 (HeLa-
Cx43C) (Omori and Yamasaki, 1999). HeLa-Cx43 cells were
well dye-coupled in FRAP experiments, and the level of
coupling was not different in HeLa-Cx43C (Figure 2, A–C).
By contrast, DF-triggered ATP release was reduced to base-
line level in HeLa-Cx43C, and the baseline level itself was
also significantly lower as in HeLa-Cx43 (Figure 2D). Sub-
sequent experiments on these cells confirmed the absence of
triggered ATP release in HeLa-Cx43C (Figures 6B, 7D, and
9E), but in one series (Figure 9B) a small significant release
component was apparent. In sum, removal of the Cx43 CT
inhibits hemichannel opening and does not affect GJs. The
intact GJ communication as shown in our experiments and
by Omori and Yamasaki (1999) indicates the presence of
Cx43C at the plasma membrane and the formation of func-
tional GJs.
Activation of PKC and c-Src Reduces GJ Communication
and ATP Responses in C6-Cx43
PMA (10 nM; 2 h), a known PKC activator (Lampe, 1994;
Malfait et al., 2001), significantly reduced dye coupling
(FRAP) in C6-Cx43 (Figure 3, A and B). Washing out PMA
during 30 min or coincubating the cells with the PKC inhib-
itor chelerythrin (250 nM; 30-min preincubation followed by
2-h coincubation with PMA) (Herbert et al., 1990) abolished
the PMA effect. PMA also significantly reduced DF-trig-
gered ATP release, and this was reversed by chelerythrin
(Figure 3C). The effect of c-Src was investigated by transient
transfection of C6-Cx43 with a vector containing constitu-
tively active or inactive c-Src. Mock transfection or transfec-
tion with the inactive c-Src mutant (c-SrcK; K295M) had no
significant effect on GJ communication, but transfection with
the constitutively active mutant (c-SrcK; Y527A) signifi-
cantly inhibited dye transfer between the cells (SLDT) (Fig-
ure 3, D and E). Triggered ATP release was affected in a
similar manner, with a significantly decreased ATP response
in c-SrcK (Figure 3F). Figure 10B illustrates Cx43 phosphor-
ylation in response to PMA and in c-SrcK.
LPA Inhibits GJ Coupling and ATP Responses in C6-Cx43,
whereas LPS Inhibits Coupling but Stimulates ATP Release
LPA activates various kinases, including PKC (Takeda et al.,
1999; Kelley et al., 2006), Src kinase (Takeda et al., 1998;
Kranenburg and Moolenaar, 2001), and the MAPK family
(Takeda et al., 1999; Kranenburg and Moolenaar, 2001). In
C6-Cx43, LPA (10 M; 1 h) significantly inhibited GJ cou-
Figure 7. Effects of bFGF are analogous to the effects observed
with LPS. (A) bFGF significantly inhibited GJ coupling (SLDT) in
C6-Cx43, and this effect was partly reversed by genistein (n is
number of SLDT images in 4 different cultures). (B) bFGF signifi-
cantly stimulated the triggered ATP release in C6-Cx43, but this
could not be reversed by genistein. (C) bFGF significantly inhibited
the triggered ATP release in HeLa-Cx43. (D) bFGF significantly
stimulated the triggered ATP release in CT-truncated HeLa-Cx43.
Stars indicate significant differences compared with control in A and
compared with baseline in B–D. The number signs in B–D indicate
significant differences compared with control.
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pling (FRAP) and DF-triggered ATP release (Figure 4). Both
LPA effects were abolished with the Src inhibitor PP2 (10
M; 15-min preincubation followed by 1-h coincubation
with LPA) or with the MEK1/2 inhibitor U0126 (20 M; 1-h
preincubation followed by 1-h coincubation with LPA) (Fig-
ure 4). The MEK1/2 inhibitor PD098.059 (50 M; same pro-
tocol as for U0126) had no significant effect, nor did the PKC
inhibitor chelerythrin (Figure 4).
LPS is another broad-spectrum kinase activator, which
binds to the Toll-like receptor and the coreceptor CD14
(Ulevitch, 1993) and thereby activates PKC, c-Src, and the
MAPK signaling pathway (Lidington et al., 2000; Lidington
et al., 2002; Schorey and Cooper, 2003). LPS (100 ng/ml; 1 h)
inhibited dye coupling (like LPA), but (unlike LPA) stimu-
lated DF-triggered ATP release (Figure 5, A and B). Both LPS
effects were reversed by PP2 and U0126 but not by chel-
erythrine or PD098.059. Gap 27 blocked the LPS-enhanced
ATP release (Figure 5C), to a similar extent as observed
without LPS stimulation (Figure 1A), whereas bafilomycin
A1 had no effect on LPS-enhanced DF-triggered ATP release
(Figure 5D). LPS can up-regulate P2X7 receptor expression in
macrophages (Le Feuvre et al., 2002), but Western blot ex-
periments did not show any evidence for such effect in
C6-Cx43 (Figure 10A). Together, LPA and LPS have oppos-
ing effects on ATP release and similar effects on GJ coupling.
These influences involve c-Src and MEK1/2 and are exerted
at the level of hemichannels. Figure 10B illustrates Cx43
phosphorylation in response to LPA and LPS.
Figure 8. Modulation of ATP release and GJ coupling by LPS, LPA, and bFGF in HeLa-Cx26 cells. (A) DF conditions triggered significant
ATP release that was stimulated by LPS and inhibited by carbenoxolone. (B) LPA inhibited triggered ATP release C. bFGF slightly but
significantly stimulated ATP release. (D) Effect of LPA and LPS on GJ coupling in HeLa-Cx26 cells as measured via FRAP, using calcein-AM
as a gap junctional-permeable dye (n is number of FRAP experiments in 2 different cultures). Stars indicate significant differences compared
with baseline in A–C and compared with control in D; number signs indicate significant differences compared with control. Carbenoxolone
also significantly depressed the baseline signal in A (p  0.05).
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LPA and LPS Inhibit ATP Responses in HeLa-Cx43, but LPS
Potentiates These Responses in CT-truncated HeLa-Cx43
To determine whether the opposing effects of LPA and LPS
on ATP release were perhaps specific for C6-Cx43, we re-
peated these experiments in HeLa-Cx43. LPA and LPS in-
hibited DF-triggered ATP release in HeLa-Cx43 (Figure 6A)
in contrast to C6-Cx43 where LPA inhibited and LPS poten-
tiated these responses. No effect of LPA was found in HeLa-
Cx43C, but quite remarkably, LPS restored the DF-trig-
gered ATP response in these cells (while giving inhibition in
nontruncated HeLa-Cx43) (Figure 6). LPS-enhanced ATP
release in HeLa-Cx43C was blocked by gap 27 and not
affected by botulinum toxin B (Figure 6B). The potentiation
of ATP release by LPS is thus, as in C6-Cx43, the conse-
quence of hemichannel stimulation.
bFGF Has Similar Effects as LPS
Basic FGF is another broad-spectrum kinase activator
(Shiokawa-Sawada et al., 1997; Mergler et al., 2003); this
substance (10 ng/ml in serum-free medium for 6 h) sig-
nificantly inhibited dye coupling (SLDT) in C6-Cx43, like
LPS and LPA, an effect that was partly reversed by the
tyrosine kinase blocker genistein (Figure 7A). The bFGF
effects on triggered ATP release were similar to those of
LPS, that is, stimulation of ATP release in C6-Cx43 and
HeLa-Cx43C and inhibition in HeLa-Cx43 (Figure 7,
Figure 9. Arachidonic acid metabolism and LPS enhancement of ATP release. (A) Inhibition of arachidonic acid production with AACOCF3,
of lipo-oxygenase with baicalein, or cyclo-oxygenase with indomethacin all drastically suppressed LPS enhancement of triggered ATP release
in C6-Cx43. Similar results were observed in HeLa-Cx43 C (B) and HeLa-Cx26 (C). (D–F) Arachidonic acid potentiated DF-triggered ATP
release in C6-Cx43, HeLa-Cx43 C, and HeLa-Cx26. Stars indicate significant differences compared with baseline; number signs indicate
significant differences compared with control.
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B–D). Stimulation of ATP release by bFGF in C6-Cx43 was
not reduced by genistein, indicating involvement of other
pathways. Figure 10B illustrates Cx43 phosphorylation
after bFGF exposure.
bFGF and LPS Potentiate ATP Release Triggered in
HeLa-Cx26
We next performed experiments on HeLa cells expressing
Cx26, which is a connexin with a very short CT domain of
only 16 amino acids, and the only connexin known not to be
phosphorylated. GJ communication was inhibited by LPA
and not affected by LPS in HeLa-Cx26 (Figure 8D). DF
conditions triggered ATP release significantly above base-
line, and this was potentiated by LPS and bFGF (Figure 8, A
and C), as observed in HeLa-Cx43C. No connexin mimetic
peptides are currently available to block Cx26 hemichannels,
so we applied carbenoxolone, which inhibited the triggered
ATP release, both in control and after potentiation with LPS
(Figure 8A). LPA inhibited the DF-triggered ATP release
(Figure 8B). LPS and bFGF thus potentiate ATP release via
hemichannels in C6-Cx43, CT-truncated HeLa-Cx43, and the
short CT connexin in HeLa-Cx26.
LPS Potentiation of ATP Responses Involves Arachidonic
Acid Signaling
The kinases activated by LPS, Src, and MEK1/2 can lead to
phosphorylation and activation of cytosolic phospholipase A2
(cPLA2) and calcium-independent phospholipase A2 (iPLA2)
(Luo et al., 2005) with subsequent production of arachidonic
acid, a proposed candidate for hemichannel activation
(Contreras et al., 2002). We investigated the involvement of
arachidonic acid and its downstream products with the cPLA2
inhibitor AACOCF3 (5 g/ml; 1 h) (Riendeau et al., 1994;
Chakraborti et al., 2004), the lipoxygenase inhibitor baicalein
(30 M; 1 h) (Vivancos and Moreno, 2002), and the cyclooxy-
genase inhibitor indomethacin (50 M; 1 h) (Fujiwara et al.,
2006). All these substances significantly suppressed LPS poten-
tiation of ATP release in C6-Cx43, HeLa-Cx43C, and HeLa-
Cx26 (Figure 9, A–C). In addition, exposure to arachidonic acid
significantly enhanced ATP release in these cell lines (Figure 9,
D–F).
Influence of LPA, LPS, and bFGF on the Cellular
Distribution of Connexins
We used Triton X-100 extraction to separate soluble and
insoluble connexin fractions. The insoluble fraction most
likely represents connexins in GJs and not in hemichannels,
because Triton X-100 insolubility is only observed after as-
sembly into GJ plaques (Musil and Goodenough, 1991, 1993;
Govindarajan et al., 2002). Treatment with LPA, LPS and
bFGF did not induce systematic and consistent changes in
the distribution of soluble and insoluble fractions in the
various cell types used (Figure 11).
DISCUSSION
Exposure to DF conditions is a well-known trigger for
hemichannel opening, and ATP release provoked in this
way proceeded through hemichannels, because it was
strongly inhibited by the hemichannel blockers gap 26 and
27 (Braet et al., 2003a,b; Leybaert et al., 2003; Gomes et al.,
2005; Pearson et al., 2005; Evans et al., 2006). A substantial
contribution of other ATP release mechanisms is unlikely
Figure 10. (A) Western blots illustrating the absence of
P2X7 receptor expression in the various cell lines and
conditions used in this study. (B) The influence of dif-
ferent kinases/kinase activators on the phosphorylation
status of Cx43 in C6-Cx43 cells. The ratio of nonphos-
phorylated versus phosphorylated Cx43 is given under
each lane, and the ratio for control conditions is con-
verted to 100%. The data are representative for three
different experiments. The effect on the phosphorylation
status can also be appreciated from the blots shown in
Figure 11 (the effect of bFGF is more clear there).
Figure 11. Western blots illustrating the separation of soluble and
insoluble connexin fractions in C6-Cx43, HeLa-Cx43, and HeLa-
Cx26 by using Triton X-100 extraction. In HeLa-Cx43, bFGF slightly
increased the soluble fraction (at the cost of the insoluble fraction),
and a similar tendency was observed for LPS in C6-Cx43. No gross
and consistent shifts were however observed over three different
experiments.
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because of the potency of the suppressive effect of the mi-
metic peptides, the absence of inhibition by the vesicular
release inhibitors botulinum toxin B (which unexpectedly
potentiated the release for unknown reasons) and bafilomy-
cin A1, the lack of P2X7 receptor expression, and the absence
of effects of P2X7 receptor antagonists.
The truncation of the CT tail of Cx43 at position 239 did
not influence GJ coupling, indicating that the CT is not
essential for the assembly and membrane insertion of GJ
channels. This confirms previous work on the same cell line
(Omori and Yamasaki, 1999) and is in line with observations
on CT truncations at slightly different positions: position 244
(Fishman et al., 1991) or 257 (Liu et al., 1993; Hur et al., 2003).
PKC activation depressed GJ coupling and ATP release via
hemichannels in C6-Cx43, in line with other studies report-
ing inhibition of dye uptake (Li et al., 1996) and NAD
release (Bruzzone et al., 2001a) via hemichannels. Recent
work shows that this occurs via phosphorylations on Ser 262
and Ser 368 of Cx43 (Bao et al., 2004c). c-Src kinase inhibits
GJs via phosphorylations at Tyr 265 and Tyr 247 (Goldberg
and Lau, 1993; Kanemitsu et al., 1997; Giepmans et al., 2001;
Lin et al., 2001), and hemichannel inhibition has also been
reported (Li et al., 1996). In line with this, v-Src inhibited
both GJs and hemichannels in C6-Cx43. The phospholipid
mediator LPA activates various protein kinases, including
PKC, Src, and the MAPK family (Takeda et al., 1998, 1999;
van Leeuwen et al., 2003; Kelley et al., 2006). LPA inhibited
GJ channels and hemichannels, and experiments with the
inhibitors PP2 and U0126 indicated involvement of Src and
MEK1/2, respectively (absence of effect of the MEK1/2 in-
hibitor PD098.059 is probably related to its poor solubility;
Davies et al., 2000; Ahn et al., 2001). MAPKs are known to
inhibit GJs (Kim et al., 1999), and our work indicates that
MEK1/2 (an MAPK family member) has a similar action on
hemichannels.
LPS, a glycolipid immunostimulant from Gram-negative
bacteria, is another activator of PKC, c-Src, and the MAPKs
(Lidington et al., 2000, 2002; Schorey and Cooper, 2003). LPS
may also stimulate NO production, but this needs exposures
longer than the 1 h used here (Shin et al., 2001). LPS reduced
GJ coupling but stimulated triggered ATP release in C6-
Cx43, and these opposite actions involved Src and MEK1/2
(reversed by PP2 and U0126, respectively). An enhancement
of ATP release may result from the stimulation of hemichan-
nels or the recruitment of other release mechanisms. LPS-
enhanced ATP release was suppressed by gap 27, to an
equal and drastic extent as observed under control condi-
tions. The strong inhibition by the mimetic peptides together
with the lack of any effect of bafilomycin A1 or botulinum
toxin B, and the absence of P2X7 receptor up-regulation in
response to LPS, indicate that the enhancement of triggered
ATP release is most likely due to stimulation of hemichan-
nels.
LPS inhibited ATP release via hemichannels in HeLa-Cx43,
and surprisingly, inhibition was turned into stimulation in
CT-truncated HeLa-Cx43. bFGF, acting on membrane-bound
tyrosine kinase receptors (Shiokawa-Sawada et al., 1997), had
similar effects, i.e., depression of GJ coupling in C6-Cx43, stim-
ulation of ATP release in C6-Cx43 and CT-truncated HeLa-
Cx43, and inhibition of ATP release in HeLa-Cx43. LPS and
bFGF also potentiated ATP release in HeLa-Cx26, a connexin
with a very short CT domain. In sum, the CT domain seems to
be necessary for hemichannel opening, whereas its absence is
required for hemichannel stimulation by LPS or bFGF in HeLa
cells.
The different effects of LPS and bFGF on different connex-
ins implicate the involvement of other signaling pathways.
LPS and bFGF can, either directly or indirectly, via interme-
diate kinases (Luo et al., 2005), lead to activation of cPLA2
and/or iPLA2 (Vivancos and Moreno, 2002; Antoniotti et al.,
2003) with subsequent production of arachidonic acid (Fig-
ure 12A). Treatment with arachidonic acid indeed mimicked
the effects of LPS and bFGF in C6-Cx43, HeLa-Cx43C, and
HeLa-Cx26, and inhibitors of arachidonic acid production or
metabolism furthermore reduced the potentiating effect of
LPS. Stimulation of hemichannels by LPS and bFGF is thus
related to the activation of the arachidonic-acid signaling
pathway. In C6-Cx43, this pathway is presumably more
active and overrides the inhibition of hemichannels by phos-
phorylations at the CT. At the level of GJs, the two pathways
lead to inhibition, as reported here for LPS and by others for
arachidonic acid (Giaume et al., 1989; Criswell and Loch-
Caruso, 1995; Velasco et al., 2000). The soluble and insoluble
fractions were not grossly or systematically affected by LPS
or bFGF treatments. Hemichannel modulation by LPS and
bFGF is therefore likely to be mediated by effects at the level
of hemichannel functioning (such as its gating) rather than
by introducing shifts in the distribution of GJ channels and
hemichannels.
Our work demonstrates that GJ channels and hemichannels,
although composed of the same connexins, can be differentially
modulated. The factors determining the hemichannel re-
sponses are related to the applied stimulus, the cell type, and
the CT domain containing the phosphorylation consensus
sites, and they depend on the balance between connexin phos-
phorylations and activation of the arachidonic acid pathway
(Figure 12B).
The role of oppositely directed responses of GJs and
hemichannels is not known, but they may serve cell-protec-
tive and restorative purposes. GJs close under pathological
conditions, for example, in response to bFGF released after
brain trauma and ischemia (Logan et al., 1992) or in response
to LPS present during bacterial infection (Campos de Car-
valho et al., 1998), and this may help to prevent the spread of
cell death-promoting factors to neighboring cells (Krysko
Figure 12. Scheme summarizing the major findings of this study.
(A) LPS and bFGF activate various kinases that suppress GJs and
hemichannel-mediated ATP release. In addition, both substances
also trigger the production of arachidonic acid (AA) via activation
of cPLA2 and iPLA2. Arachidonic acid is known to inhibit GJs, and
the present study demonstrates that it stimulates hemichannel-
mediated ATP release. (B) We conclude that the net effect of LPS and
bFGF depends on the balance between activation of kinases, inhi-
bition of hemichannels, and activation of the arachidonic acid met-
abolic pathway, stimulating hemichannel-mediated ATP release. In
HeLa-Cx43 cells the kinase component predominates, whereas in
C6-Cx43 it is the arachidonic acid pathway that adds most weight.
Truncation of the CT in HeLa-Cx43 removes inhibition by kinases
and thereby reveals the arachidonic acid component.
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et al., 2005). In this case, paracrine ATP signaling via
hemichannels may be solicited to compensate for the lost GJ
communication. Moreover, ATP release via hemichannels
may stimulate the recovery of injured tissues (e.g., brain and
liver) by its mitogenic actions (Thevananther et al., 2004;
Pearson et al., 2005) and its vasodilatory and neuroprotective
degradation product adenosine (Erlinge, 1998; Burnstock,
2002; Stone, 2002). Hemichannels can, however, also be con-
sidered as pathogenic pores promoting cell death (Evans et
al., 2006), and closure of both GJs and hemichannels may
thus be preferred when cell protection is the primary target.
We conclude that the immunostimulant LPS and the growth
factor bFGF exert a powerful control over hemichannel ATP
release, with inhibition or stimulation being determined by
the cell type, the intracellular signaling machinery, and the
connexin type present. Given the pleiotropic effects of extra-
cellular ATP, these results suggest that the final effect of LPS
and bFGF may, in addition to the various intracellular cas-
cades activated by these agents, also depend on hemichan-
nel modulation.
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